Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12026-06-03NCT06040541

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Revolution Medicines, Inc.18

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Carolina BioOncology InstituteHuntersvilleUnited States22
Dana-Farber Cancer InstituteBostonUnited States626
Duke Cancer CenterDurhamUnited States44
Florida Cancer SpecialistsSarasotaUnited States47
Johns Hopkins UniversityBaltimoreUnited States150
Lee Moffitt Cancer CenterTampaUnited States1
Massachusetts General HospitalBostonUnited States1015
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
NEXT Oncology VirginiaFairfaxUnited States40
NYU LangoneNew YorkUnited States34
Sarah Cannon Research InstituteNashvilleUnited States119
Sarah Cannon Research Institute at Mary CrowleyDallasUnited States7
Smilow Cancer Hospital (Yale University)New HavenUnited States1
STARTSan AntonioUnited States5
The Christ HospitalCincinnatiUnited States81
University of California, Davis Comprehensive Cancer CenterSacramentoUnited States18
University of Texas, MD Anderson Cancer CenterHoustonUnited States12